Mupirocin calcium ointment, 2%

DRUG3 trials

Sponsors

Columbia University, Solventum US LLC, VA Office of Research and Development

Conditions

HIV InfectionsHuman MicrobiomeStaphylococcus AureusSurgical Site Infection

Phase 4

Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection

CompletedNCT00801879

Columbia UniversityHIV Infections, Staphylococcus Aureus

Start: 2003-09-30End: 2006-04-30Updated: 2014-10-29

Prevention of Surgical Site Infections: Effectiveness of Nasal Povidone-Iodine and Nasal Mupirocin

CompletedNCT01313182

Solventum US LLCSurgical Site Infection

Start: 2011-03-31End: 2012-09-30Updated: 2024-12-02

Cultures Before and After Decolonization in Community Dwelling Adults With Current S. Aureus Colonization

CompletedNCT04222699

VA Office of Research and DevelopmentHuman Microbiome

Start: 2012-09-18End: 2014-11-18Updated: 2020-04-14

Related Papers

Preventing Surgical Site Infections: A Randomized, Open-Label Trial of Nasal Mupirocin Ointment and Nasal Povidone-Iodine Solution

Infection Control and Hospital Epidemiology2014-05-21154 citations